Renviva, Llc is a medicare approved dialysis facility center in Rockford, Illinois. It is located in Winnebago county at 1235 N. Mulford Road, Rockford, IL, 61107. You can reach out to the office of Renviva, Llc at (779) 423-1254. This dialysis clinic is run as an independent entity, i.e. it is not owned by any chain organization. Renviva, Llc has the following ownership type - Profit. It was first certified by medicare in August, 2016. The medicare id for this facility is 142803 and it accepts patients under medicare ESRD program.
| Name | Renviva, Llc |
|---|---|
| Location | 1235 N. Mulford Road, Rockford, Illinois |
| Medicare ID | 142803 |
| Ownership Type | Profit |
| Late Shifts | No |
| Dialysis patients with Hemoglobin data | 8 |
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
| Adult patients getting regular hemodialysis at the center | 18 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 91 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 88 |
| Adult patients getting regular peritoneal dialysis at the center | 20 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 120 |
| Percentage of adult peritoneal dialysis patients with Kt/V greater than or equal to 1.7 | 70 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Renviva, Llc with elevated calcium levels.
| Patients in the hypercalcemia summary | 41 |
| Hypercalcemia patient months | 228 |
| Percentage of adult patients with serum calcium greater than 10.2 mg/dL | 11 |
| Patients in the serum phosphorus summary | 43 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 7 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 26 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 29 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 22 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 16 |
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 24 |
| Patient months included in arteriovenous fistula and catheter summaries | 111 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 51.1 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 23 |
The rate of hospitalization shows you whether patients who were being treated regularly at Renviva, Llc were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 31 |
| Hospitalization Rate in facility | 196.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 350.8 |
| Hospitalization Rate: Lower Confidence Limit | 117.9 |
The rate of readmission shows you whether patients who were being treated regularly at Renviva, Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 35.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 51.1 |
| Readmission Rate: Lower Confidence Limit | 21.4 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Renviva, Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 14 |
The rate of mortality shows you whether patients who were being treated regularly at Renviva, Llc lived longer than expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 263 |
| Mortality Rate in facility | 39.1 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 52.8 |
| Mortality Rate: Lower Confidence Limit | 29.2 |
Davita Forest City Dialysis Location: 198 North Springfield Avenue, Rockford, Illinois, 61101 Phone: (815) 962-8914 |
Davita Owen Center Home Training Location: 3927 W. Riverside Blvd, Rockford, Illinois, 61101 Phone: (815) 963-8010 |
Davita Rockford Dialysis Location: 3339 N. Rockton Ave, Rockford, Illinois, 61103 Phone: (815) 636-4493 |